Adrenergic Receptors

Items 801-827 of 827

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Adrenergic Receptor

    Methoxyphenamine is a β-adrenergic receptor agonist belonging to the amphetamine class, primarily utilized as a bronchodilator. This compound demonstrates significant biological activity in promoting airway smooth muscle relaxation, making it useful in the treatment of bronchial constriction. Its applications extend to research in respiratory diseases and the pharmacological modulation of adrenergic pathways.
  2. β-agonist

    Isoetharine hydrochloride is a selective, short-acting β-agonist primarily used as a bronchodilator. Its ability to stimulate β-adrenergic receptors makes it important for research applications involving respiratory therapies and inhalation studies. This compound aids in the exploration of therapeutic strategies for bronchoconstrictive diseases such as asthma and chronic obstructive pulmonary disease (COPD).
  3. α1/α2 Adrenergic Receptor Antagonist

    Phentolamine is a selective and orally active antagonist of α1 and α2 adrenergic receptors. This compound exhibits significant biological activity in modulating vascular tone and has been extensively utilized in research related to erectile dysfunction and adrenergic signaling. By inhibiting these receptors, Phentolamine promotes vasodilation and enhances blood flow, making it a valuable tool for studying cardiovascular and reproductive systems.
  4. β2-adrenergic receptor Agonist

    Methoxyfenoterol is a selective β2-adrenergic receptor agonist known for its ability to stimulate intracellular cAMP accumulation. It exhibits significant anti-proliferative effects on tumor cells by inducing G1 cell cycle arrest, upregulating p27, and downregulating cyclin D1 and cyclin A levels, while also inhibiting Akt phosphorylation. Additionally, Methoxyfenoterol is capable of crossing the blood-brain barrier, demonstrating efficacy in inhibiting the growth of astrocytoma xenografts. This compound is primarily utilized in research related to astrocytoma and glioblastoma.
  5. PN-1 Agonist

    Serpinin is an agonist of the protease inhibitor Nexin-1 (PN-1), promoting its expression through the cAMP-PKA-Sp1 signaling pathway, which enhances granule biogenesis in endocrine cells. This compound is instrumental in studying the regulation of secretory functions and demonstrates selectivity for β-adrenergic receptors. By interacting with β1-adrenergic receptors, Serpinin activates the AC-cAMP-PKA pathway, crucial for regulating myocardial systolic and diastolic function. Additionally, pGlu-serpinin has been shown to upregulate Bcl2 mRNA transcription, contributing to its neuroprotective effects.
  6. 5-HT/NE Reuptake Inhibitor

    Dextromilnacipran is a selective serotonin and norepinephrine (5-HT/NE) reuptake inhibitor, derived from the enantiomeric form of milnacipran. This compound also functions as a human alpha-adrenergic receptor antagonist, exhibiting an IC50 value of 3.4 μM. Dextromilnacipran is primarily utilized in research applications targeting mood disorders and neuropharmacology, facilitating investigations into its psychiatric and physiological effects.
  7. Stable Isotope

    Dextromilnacipran-d6 is a deuterium-labeled analog of Dextromilnacipran, a selective serotonin and norepinephrine (5-HT/NE) reuptake inhibitor. This compound also acts as a human alpha-adrenergic receptor antagonist, exhibiting an IC50 of 3.4 μM. Dextromilnacipran-d6 is a valuable tool for metabolic and pharmacokinetic studies, providing insights into the behavior and efficacy of 5-HT/NE reuptake inhibitors in various research contexts.
  8. ARα2c Inhibitor

    BAY-2925976 is an α2C adrenergic receptor (ARα2C) inhibitor that selectively blocks receptor activity. This compound is primarily utilized in research related to obstructive sleep apnea (OSA), providing insights into its underlying mechanisms and potential therapeutic approaches. BAY-2925976 aids in elucidating the role of ARα2C in respiratory regulation and sleep disorders.
  9. β-AR Antagonist

    Lubabegron fumarate is a selectiveβ-adrenergic receptor (β-AR) modulator, exhibiting antagonistic properties at both β1 and β2 receptor subtypes while acting as an agonist at the β3 subtype in bovine species. This compound effectively reduces ammonia (NH3) gas emissions from livestock and their waste, making it a valuable tool for improving environmental sustainability in agricultural practices. Lubabegron fumarate is primarily used in research applications focused on animal health and emissions management.
  10. Drug Impurity

    Mirabegron impurity 6 is a recognized impurity of the pharmaceutical compound Mirabegron, which primarily acts as a β3-adrenergic receptor agonist. It serves as an important reference standard for quality control in the synthesis and analysis of Mirabegron and is crucial in ensuring the purity and efficacy of the drug. This impurity can assist in research applications involving pharmacokinetics, safety assessments, and metabolic studies of β3-adrenergic modulators.
  11. Drug Impurity

    Tamsulosin impurity 15 is a chemical impurity associated with the pharmaceutical compound Tamsulosin, which primarily targets alpha-1 adrenergic receptors. This impurity is relevant for quality control and characterization in the development and analysis of Tamsulosin formulations. Research applications include assessing the purity and safety profiles of Tamsulosin in pharmaceutical formulations.
  12. Drug Impurity

    (S)-Tamsulosin hydrochloride is a chiral impurity associated with the pharmaceutical compound tamsulosin, primarily targeting alpha-1 adrenergic receptors. This reagent may serve a critical role in the analytical characterization and quality control of tamsulosin formulations. Its presence can impact the pharmacological profile and efficacy of the drug, making it an essential component for research and development in pharmaceutical sciences.
  13. Drug Impurity

    Acebutolol impurity 7 is a secondary compound generated during the synthesis of Acebutolol, a selective beta-1 adrenergic receptor blocker. This reagent is primarily utilized in drug development and quality control to ensure the purity and safety of pharmaceutical formulations. Its characterization and analysis are essential for compliance with regulatory standards in chemical research and formulation studies.
  14. Drug Impurity

    Dexmedetomidine impurity 2 is a chemical impurity related to Dexmedetomidine, a selective alpha-2 adrenergic receptor agonist. This impurity is significant in assessing the purity and quality of Dexmedetomidine formulations. It is utilized primarily in analytical chemistry and pharmaceutical development, particularly for the evaluation of drug substances and ensuring compliance with regulatory standards.
  15. Drug Impurity

    Alfuzosin EP impurity 1 hydrochloride, also known as 2,3,4,5-Tetradehydro alfuzosin hydrochloride, is a recognized impurity of Alfuzosin hydrochloride. This compound is essential for evaluating the purity and stability of alfuzosin formulations in pharmaceutical development. Researchers may utilize this impurity in studies assessing drug quality, pharmacokinetics, and mechanism of action related to alpha-1 adrenergic receptor antagonism.
  16. Adrenaline Impurity

    Methoxy adrenaline hydrochloride is a synthetic analog of adrenaline, serving as a known impurity in adrenaline formulations. Its presence is critical for quality control in pharmaceutical research, allowing for the assessment of purity and stability in adrenaline products. This compound can also be utilized in various biological studies to investigate adrenergic receptor interactions and signaling pathways.
  17. Drug Impurity

    Metoprolol Impurity 13 is a chemical impurity associated with Metoprolol, a selective beta-1 adrenergic receptor antagonist. This impurity can be utilized for analytical purposes in drug development, including stability studies and quality control assessments. Researchers can employ this compound to ensure the purity and compliance of Metoprolol formulations in pharmaceutical applications.
  18. Drug Intermediate Control

    (Rac)-7-Methoxy propranolol is a key synthetic intermediate that plays a critical role in the production of pharmaceuticals. This compound is utilized in drug formulation and development, particularly in studies related to beta-adrenergic receptor antagonism, which is important for cardiovascular research. Its chemical structure facilitates various synthetic pathways in the creation of effective therapeutics.
  19. Drug Impurity

    Tamsulosin impurity 5 is a known impurity associated with Tamsulosin, a selective alpha-1 adrenergic receptor antagonist primarily used to treat benign prostatic hyperplasia. This specific impurity plays a crucial role in quality control and analytical studies aimed at evaluating the purity and stability of Tamsulosin formulations. It is essential for researchers focusing on the pharmacokinetics and safety profiles of the drug.
  20. Drug Impurity

    Mirabegron impurity 12 is a known impurity associated with the pharmaceutical compound Mirabegron, which primarily acts as a β3-adrenergic receptor agonist. This impurity may be important for analytical characterization and quality control in pharmaceutical research and development. Its detection and quantification can aid in understanding the safety and efficacy profiles of Mirabegron formulations.
  21. Drug Impurity

    Brimonidine impurity 3 is a chemical impurity associated with the drug Brimonidine, primarily targeting adrenergic receptors. This compound is relevant for quality control in pharmaceutical formulations and can be utilized to study the stability and degradation pathways of Brimonidine. Its characterization contributes to the development of safer and more effective drug products.
  22. Drug Impurity

    Carvedilol impurity 13 is a known impurity of the beta-blocker carvedilol, which primarily targets beta-adrenergic receptors. This compound is utilized in pharmaceutical research to assess the purity and stability of carvedilol formulations. Its characterization is essential for ensuring compliance with regulatory standards and improving drug quality.
  23. β-Adrenergic Receptor Agonist

    Methoxyphenamine hydrochloride is a selective β-adrenergic receptor agonist that acts primarily as a bronchodilator. This compound enhances airway patency by relaxing bronchial smooth muscle, making it beneficial in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its application in research focuses on studying β-adrenergic signaling pathways and pharmacological responses in respiratory physiology.
  24. β-adrenergic Receptors Agonist

    Isoetharine mesylate is a selective agonist of β-adrenergic receptors, exhibiting oral bioactivity. By promoting the production of cyclic AMP (cAMP), it facilitates the relaxation of smooth muscle cells. Isoetharine mesylate is primarily utilized in research related to respiratory conditions, including emphysema and bronchitis, where it serves as a bronchodilator to aid in airway relaxation and improved airflow.
  25. α-Adrenergic Agonist

    Metaraminol tartrate is an α-adrenergic agonist that functions primarily as a vasopressor agent. This sympathomimetic amine exerts its effects by directly and indirectly stimulating adrenergic receptors, with a predominant activity on alpha receptors. It is utilized in research applications involving cardiovascular physiology and the modulation of vascular tone.
  26. β1/α1-adrenergic Receptor Antagonist

    Bevantolol hydrochloride is a selective β1 and α1-adrenergic receptor antagonist. With pKi values of 7.83 for the β1 receptor and 6.9 for the α1 receptor in rat cerebral cortex, it demonstrates significant antagonistic activity. Additionally, Bevantolol hydrochloride exhibits potent calcium (Ca2+) antagonism, making it a valuable tool for research applications in cardiovascular studies and related therapeutic areas.
  27. Adrenaline Antagonists

    Prazosin is an α-adrenergic receptor antagonist primarily targeting adrenaline pathways. It exhibits significant biological activity in reducing inflammation, alleviating anxiety and panic, and preventing cognitive decline associated with Alzheimer's disease. Additionally, Prazosin modulates the analgesic effects of opioids, making it a valuable compound for research applications in hypertension and neurodegenerative disorders.

Items 801-827 of 827

Page
per page
Set Descending Direction